Because both TGFβ and EGF attenuate AD in vivo and ERK activation in keratinocytes regulates skin inflammation [17,18,19], we hypothesized that the ERK-activating peptide, AES16-2M, could also ameliorate AD. This evidence concerns the gene TGFB1 and Alzheimer disease.